The post Hyperliquid Tests Outcome Trading as Prediction Markets Heat Up appeared on BitcoinEthereumNews.com. Hyperliquid mentioned that outcomes target puttingThe post Hyperliquid Tests Outcome Trading as Prediction Markets Heat Up appeared on BitcoinEthereumNews.com. Hyperliquid mentioned that outcomes target putting

Hyperliquid Tests Outcome Trading as Prediction Markets Heat Up

2 min read
  • Hyperliquid mentioned that outcomes target putting up non-linearity and dated contracts while proposing a form of derivatives trading.
  • Polymarket has once again entered the US market after it got approval from the CFTC via an amended order of designation. 

Hyperliquid is planning to set its foot into prediction markets, rolling out a new product known as outcome trading that guarantees to open the door to event-based contracts without the leverage and liquidation mechanics that influence the crypto derivatives. 

On January 2, Hyperliquid posted on X, saying that its main engine, HyperCore, will back outcome trading under a proposal said to be HIP-4, structuring outcomes as completely collateralised contracts that sit down within a fixed range and can boost prediction markets and bounded options-style trades. 

Hyperliquid mentioned that outcomes target putting up non-linearity and dated contracts while proposing a form of derivatives trading that does not depend on leverage or liquidations. 

It also placed the feature as a factor that can operate in company with portfolio margin and HyperEVM, indicating a push to broaden what developers can make on top of the pile. As of the current scenario, the firm mentioned that the feature is still in testnet, with canonical markets planned after technical work concludes. 

The Transformed Competitive Landscape

Hyperliquid further went on to mention that those initial markets will depend on objective settlement sources, be termed in USDH and may further widen to unauthorised deployment relying on user feedback. 

The timing matters, as prediction markets are shifting from the periphery to the regulatory agenda. The Chairman of the Commodity Futures Trading Commission, Michael Selig, revealed last week that the agency is all set with a new rulebook for prediction markets, as platforms like Polymarket and Kalsi have captivated billions in activity after allowing users to trade yes or no outcomes over politics, pop culture and more.  

This regulatory shift has so far transformed the competitive landscape. Polymarket has once again entered the US market after it got approval from the CFTC via an amended order of designation, an action that could make event contracts a new engagement tool for prominent crypto platforms like Coinbase, as reported in a Clear Street report by analyst Owen Lau. 

Highlighted Crypto News Today: 

Ethereum Treasury Firm BitMine Faces $7B Unrealized Loss Amid Crypto Downturn

Source: https://thenewscrypto.com/hyperliquid-tests-outcome-trading-as-prediction-markets-heat-up/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29